SAN DIEGO, CA, May 8, 2013 − Visage Imaging, Inc., a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), announced today that they have signed a five-year agreement with vRad (Virtual Radiologic), one of the world’s largest radiology groups.
vRad, whose more than 400 radiologists read 7 million radiology studies annually, will implement the Visage 7 Enterprise Imaging Platform as a central component of its technology platform focused on delivering a real-time, ‘read anywhere, read anytime’ environment. This will enable vRad to dynamically orchestrate when and by whom studies are read from anywhere within their owned partner radiology groups (hospitals and offsite), as well as their vast teleradiology network.
“We performed an extensive analysis of the market before making our decision,“ said Jordan Halter, vRad’s Vice President of Business and Clinical Strategy. “Visage 7’s speed and clinical depth immediately impressed us and we couldn’t be more excited. Visage is a key component of our technology platform and will enable us to rapidly stream even the largest radiology cases, to the most appropriate radiologist for interpretation, while also providing the most comprehensive clinical tools available.” The first phase of Visage implementations are planned for Diagnostic Imaging, Inc. (DII) and the New York Radiology Alliance (NYRA), both part of the vRad Alliance Network. Mr. Halter added, “I’ve been fortunate to be in Medical Imaging and Medical Informatics for many of the formative years and there is no doubt that the Visage viewer and architecture provides tremendous advantages and flexibility for those looking to thrive in a consolidating market.”
Dr. Sam Hupert, Chief Executive Officer, Visage Imaging and Pro Medicus said, “We are extremely pleased to be part of this key initiative. vRad is leveraging the unique strengths of Visage 7 enabling their technology platform to meet the dynamic needs of integrated hospital-based and remote reading requirements. It is a platform for the future, one that has unparalleled scalability, clinical depth and speed, all of which are critical especially in the highly competitive North American radiology market.”
Commenting on the commercial aspects of the deal, Dr. Hupert said, “This is a key milestone for us. The first phase of the rollout is material in its own right yet represents a relatively small percentage of vRad’s overall volume, so there is potential for very significant upside in this contract. A deal of this magnitude, with such a large and prominent client, helps put us firmly on the map in the US market.”
Please join Visage Imaging and learn more about the Visage 7 Enterprise Imaging Platform at the upcoming SIIM 2013 Annual Meeting, Grapevine-Dallas, TX, June 6-9, 2013 at Booth 610. While at SIIM, plan on joining the following Visage Imaging speakers during the conference:
• Applied Learning Vendor Tie-In Session: Who Do You Turn to for Help in Developing Solutions?” Friday, June 7, 1:15 pm – 2:45 pm – Brad Levin, MBA (General Manager, North America, Visage Imaging)
• Innovation Theater Session: “Advanced Image Analysis: The Vendor Perspective” Friday, June 7, 2:45 pm –
3:45 pm – Tim North, ASN (Senior Clinical Product Specialist, Visage Imaging)